Eastern Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Eastern Bank's NVS Position: Q3 2026 in Review
Eastern Bank reduced its Novartis (NVS) stake by 5.2% in Q3 2026, selling an estimated $53.4K and leaving 6,392 shares worth $911K. The position accounts for 0.01% of the portfolio, ranked #212.
Eastern Bank first reported a position in NVS in Q1 2014 and has held it in 17 quarters since. The position peaked at $19.8M in Q3 2024. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Eastern Bank held 6,392 shares of Novartis worth $911K as of Q3 2026.
- Eastern Bank sold 352 Novartis shares in Q3 2026, an estimated $53.4K.
- Novartis made up 0.01% of Eastern Bank's portfolio in Q3 2026, its #212 holding.
- Eastern Bank first reported a position in Novartis in Q1 2014 and has held it in 17 quarters since.
- Eastern Bank's Novartis position peaked at $19.8M in Q3 2024.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.